Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Record number of serious injuries and deaths reported from prescriptions

Executive Summary

The Institute for Safe Medication Practices reported Oct. 23 that serious injuries and deaths associated with drug therapy were reported for a record total of 20,745 people during the first quarter of 2008, including 4,824 deaths. The number of injuries is 38 percent higher than the average for the previous four quarters, while the number of deaths represented a 2.6 fold increase from the previous quarter. Deaths also counted for a greater percentage of serious injuries, 23 percent, compared to the historical average of 16 percent. ISMP culls its data from FDA's MedWatch program and reports submitted through the agency's Adverse Event Reporting System. Consumers currently make up the majority of those reporting to this system, surpassing physician reporting in 2006 (1"The Pink Sheet," June 23, 2008, p. 17)

You may also be interested in...



Adverse Event Reporting Soars As Consumer Submissions Pass Physicians

The growth in submissions to FDA's Adverse Event Reporting System is being driven primarily by consumers, according to 10 years of data released by the agency

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS050274

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel